Benefits
Targeting metastasis’s multipath mechanisms
Neutralizing tumor associated pathogens
Regulating drug efflux proteins
Activates the lymphocyte immune cells
Regulating Mitochondrial Dysfunction
Onco Punch Is
- Anti-Multi Drug Resistance
- Anti- Invasive
- Anti-Proliferative
- Anti-angiogenic
Clinically Tested Formula
No Foul smell and No Burping
No harmful heavy metals
100% Natural Actives
Onco Punch
₹1,999 – ₹3,999
Onco Punch is designed to target cancer metastasis by regulating drug resistance, neutralizing tumor pathogens, and activating immune cells. It combats multidrug resistance, invasive cancers, and relapsed tumors. Ideal for those in palliative care or with metastasized cancers.
Who should take it ?
If anyone in precarious situation such as
- Palliative Care
- Multidrug resistance
- Terminally ill conditions
- Metastasized cancers
- Relapsed tumors
- Delocalized cancers
- Cancers spreader to other parts of the body
Why should take it ?
Tata Memorial study identifies toxicity-reducing agent, holds out hope for cancer patients
Doctors at Tata Memorial Centre here say they have discovered a mechanism for cancer metastasis and developed nutraceutical therapy to minimize its risk.
Antiproliferative and palliative activity of flavonoids in colorectal cancer
Flavonoids nanostructures promising therapeutic efficiencies in colorectal cancer
‘Palliative-D’—Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial
Effect of Vitamin D3 Supplements on Development of Advanced Cancer A Secondary Analysis of the VITAL Randomized Clinical Trial
Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple Mechanisms
Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection
Dosage & Duration
Daily Use
Suitable for daily use
1 Capsule
1- capsule a day
morning
Preferably in the morning
Avoid
Avoid coffee or tea for 30-45 mins
Safer dosage
Safer dosage for chronic conditions
Media Coverage
